Infliximab in chronic myelogenous leukemia

MeSH terms

• Antibodies, Monoclonal / administration & dosage*
• Arthritis, Rheumatoid / drug therapy
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Follow-Up Studies
• Fusion Proteins, bcr-abl / genetics
• Humans
• Infliximab
• Injections, Intravenous
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Male
• Methotrexate / administration & dosage
• Middle Aged
• Neoplasm, Residual / diagnosis
• Neoplasm, Residual / drug therapy*
• Reverse Transcriptase Polymerase Chain Reaction / methods
• Treatment Outcome